Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bottom line is this, we have 3, 6, 9 months max until we get the final verdict. If within this duration they decide to tweak again, delay, etc it's over for them. Pretty much everyone is at there whits end. Most will sell and they won't be able to raise enough cash at .50 to survive the new delay. If this past month or two has not clued them in on this then they deserve insolvency.
I do not include one more potential dilution raise as the nail in the coffin AS LONG as they remain on track. I personally believe we will get a nice chunk from the 3.20's to avoid another dilution raise. However, let's say they do another raise in Jan/Feb the pain will be short lived as design freeze, CE Mark, FDA, etc, etc would only be a couple months away at that point in time. The $2 levels will be long gone by then
The silence and not supporting this raise and R/S has been very disappointing. I'm giving Mc a mulligan on this one. The Nov delay was at the urging of Estape and other SAB members. Not pinning that one on Mc. As far he knew at that point they were still on track.
Just remember, were basically in September. A few more months and its 2019, which means game on. It will be nice to say design freeze this year, CE Mark this year, FDA this year will be cutting it close, but you get the point.
NO MORE DAMN DELAYS, then were looking really good. I'd rather have a game/market changing product and have to deal with some financing, PR flubs, then a crap product and a flawless to market execution.
GLTA
I don't think traveling every week, living out of a suitcase, getting bombarded daily with angry investors (although this last raise fiasco was self inflicted) amounts much to a quality of life.
Both points are valid. Put it this way, say your making 100k/year, but could easily be making 200k elsewhere. Only a moron wouldn't leave to double there salary. Unless there was something of vast intrinsic value keeping you at your current job. otherwise why leave 100k on the table. How do you justify that to your spouse, family, etc. And for the record, Mc's wife does check the pps, and isn't shy about giving him grief. I'm sure the last month he has been getting an earful at work and at home.
As great as it would be for him to throw in his own money, I'm keeping a close eye on if he and others get granted new options at this pathetic price. They eventually will, since it's a common executive practice, but I'm really hoping it's not at these levels.
As of today, he is not walking away from this thing for anything under $25-30 minimum.
GLTA
Dual exchanges is making this an even bigger cluster F. 25-30 mil is my sweet spot, but wouldn't be surprised at 15-20. I've learned to lower my expectations with Titan through the years.
We will also be getting a company update (call) in August. Not exactly sure when, but details should be in a week or so.
Was also confirmed that absolutely nothing is wrong as far as delay. Just the OSC and procedural issues as usual.
Thanks BKT, that correlates with the info I was given by a different source.
30 mil is my sweet spot. enough to raise some eyebrows and get them pretty close to the promise land, and a little less dilution in the long run. If they can't get the rest from warrants down the road, or partnerships then get a damn personal loan from Discover.
Got nothing, just mad I keep buying on the way down recently. Bought at 6.75. Could have doubled my shares 2 weeks later. Not happy with all this, but nothing has changed fundamentally. Still think we'll be just fine in the end, just not as huge a payday with all this dilution. I'm too stupid to not check pps for a few weeks.
Not an attack, just seems odd why some people on here, who apparently are heavily invested in a stock, would trash the very own company there invested in...especially when the company has made huge strides recently and tons of momentum at there back. Weird strategy I guess...
Not to be a downer, but I don't believe there is any chance of a surprise design freeze announcement any time soon. Still looking at 2019. However, just to be clear, I would gladly like to be wrong on this one. Mc does seem like the type to under promise/over deliver.
GLTA
Just to add to your post BigT, the new COB should/will be announced between the AGM and end of this month. As long as it's not Martin Shkreli, I'm expecting it to be a stud in the industry.
GLTA
The good news for you is that your cost basis is basically where Mc's is. He's not getting out of this thing without making a chunk on those 8 mil @.57
I believe you are correct on both fronts. Mc's business style is conservative by his own admission (i.e. under promise/ over deliver). Although we knew they were going to do this the timing is earlier then I thought. I was thinking late summer.
With that in mind they must be VERY confidant to do this now. They have been on the road constantly over the past few months. From what we've heard it's been going extremely well.
Your safest bet is probably to hold what you have, and then check the couch cushions for spare change if it slumps after R/S.
GLTA
Exactly. Sadly ihub has all but turned into Bellevue's forum board.
Not meeting goals??? What company are you following?
No, uplist is still the plan. Just not sure when. BigT is right, however the conf call is slated for July (mid year update). No reason to do it now with the AGM in two weeks 6/14. Genova will also be giving updates on product development, and Jensen updates on regulatory.
for those wondering why we are still positive with David and his team is there record. A sliver of DD on David and his team shows successes everywhere he's been. Put his record with game changing SPORT technology and I feel just fine with my investment. Not that I like our crappy pps, but he's been here a year and a half.
GLTA
Sure, nothing like being an expert in the your field and getting the future of your market completely wrong. Its a small community. Everybody who Is somebody knows each other. Yes, there reputation will take a hit. I.e, is that Dr. Patel, isn't he the one who went all in on that pos titan medical company.
Sure there getting paid, but not sure why they would put there reputations on the line promoting a dog.
Don't forget about those SAB losers. If only these world renown robotic surgeons knew the real truth about this company...
Also, once we uplist to a different exchange, we can execute raises more privately without the public scrutiny.
I don't believe the pps will tank after a r/s. It is well known by folks on here that MC is acutely aware of the pitfalls of a r/s and plans to support it with PR's, news, updates, etc. Access to institutional investors (new money) should also help support the stock. Again, no guarantees, but if it gets us off this godforsaken exchange...I'm all in.
GLTA
Impressive analysis, thanks for playing...
False, uplist to Nasdaq, etc is major news. Opens the flood gates to big money institutions. probably within 60 days.
We will probably be around a buck when design freeze hits.
I think your probably right. I'd be out of there if it were me. 8 million plus options and a clinical game changer in robotics endorsed by world renowned robotic surgeons. No brainer...
I think its time to move on dude...
If in 3 plus years this thing fails, I'm sure Mc will feel some pain and regret that he didn't take the sure thing at "Company X" where he could have had another 750k in the bank. Sure, it would be great if he threw in some of his own money, but it's like 20th on my list of importance. We'll just agree to disagree. However, I do appreciate the constructive criticism on here. We have the same end game.
He's "losing" 250k a year by working at Titan right now. He's 57 and in the prime of his earning potential.
I believe Mc's salary is between 200-250k. To mustangs point, at this stage in his career he could easily be making 500k+ elsewhere. He's leaving MINIMUM 250k on the table each year he's here with Titan. Don't know about you, but if I had 8mil plus in options at .57 I would be working 23 hour days, drinking 10 red bulls/day, and do anything borderline illegal to get SPORT to the finish line
I don't think he's sitting in his office with his feet on the desk with a cigar counting his middle management salary.
Yes, the prospect of more dilution is concerning, but remember once we uplist its a whole different ball game regarding funding. The access to institutional funds and private raises (instead of all these public gut punches) will be much less detrimental to Titan.
Agreed. Cautiously optimistic they won't need the human trials, but with our luck who knows... The good thing is Titan should find out soon which way this goes. Curious if David will make public what transpires.
Also keep in mind, even if human studies are needed the next question is how many patients are needed. There is a big difference between 10 and 100 as far as timeline is concerned. Obviously 10 would be much preferred and would still reduce the already revised timeline since titan is factoring in a larger patient model.
It's definitely down to the wire, but still think we get the news tomorrow.
If we don't get it, I'll have to consider dumping Susan Wilkins as my secret source.
It's was an amicable departure, and it sounds like general personal reasons. Although, the big question is if he is selling or plans to sell his shares. It doesn't appear so, but not 100%. Time will tell.
Not sure, but guessing they are saving some news to support uplist. More important then providing news/support for road shows...imo
To an extent they are concerned about the pps level, but it sounds like a 10/1 or 15/1 is there goal. If human studies are not required then it does shorten the timeline and looking around mid 2019 for FDA without human studies. Also, even if human studies are required then another factor involved is how many patients are required. Big difference between 10 or 100 patients as far as timeline is concerned.
We'll get both software announcement and raise totals in the next week or two. Uplist is becoming more and more inevitable within the next 30-90 days (sooner than later imo). Assume a r/s somewhere in the mix as well. Good chance of a Patel video sometime soon. Looking like a more active 2018 then recently thought.
GLTA
Shocker for me. Not necessarily good news. He had deep pockets. He either is pissed like we all are with the recent raise and delay. (Although still should be for the best in the long run. Short term sucks). Or Mc nudged him out of the way. The good news is barker is taking his place and he's more involved and knows his stuff. He also spearheaded the search for a new CEO when they brought on Mc.
Only way it really hurts is if he sells. If he doesn't maybe just a personal decision. Either way we need some positive news. I believe the next month or two is going to be busy.
Glta
Yes, Titan is e,exhibiting here.
Thanks Fly. Understand the frustration of the longtermers, but still very confidant after the progress over the past year.